Appointment of deputy general manager

Appointment of Sandrine Carle
as deputy general manager

Ecully, November 7, 2023-The Spineway Group, specialists in innovative implants for the treatment of serious spinal disorders, announces the appointment of Sandrine Carle as Deputy Chief Executive Officer. Ms. Carle joined Spineway in July 2022, at the time of the acquisition of Spine Innovations, where she was CEO. She was instrumental in the successful integration of Spine Innovations into the Spineway Group.

After obtaining a degree in biomedical engineering (UT Compiègne) and an Executive MBA at HEC in Paris, Sandrine Carle worked for more than 20 years in the orthopedic surgery sector, and more specifically in the spine surgery sector at Medtronic (Europe), Kyphon (USA) and Vexim (France). She held marketing and management positions in France and the US before being appointed CEO of Spine Innovations in 2020.

Ms. Carle led the creation of this entity following a spin-off in 2020¹ and the development of this activity between 2020 and 2022. She led the recruitment and management of about fifteen employees, set up the functional and operational organization of the team and also obtained the company’s certification from the notified body G-MED (France ).

Together with Stéphane Le Roux, CEO of Spineway, Sandrine Carle is responsible for executing the Group’s overall roadmap, in particular the business development plan aimed at returning to operational break-even,² as well as all R&D projects (short, medium and long term).

Stéphane Le Roux said: “I am pleased that Sandrine is joining me as Deputy Chief Executive Officer of Spineway. I am confident that her leadership, strategic insight and deep market knowledge will help shape our future. She will strengthen our highly experienced management team. Sandrine will also lead the Group’s development plan as we remain committed to our core values of quality and innovation. She will work closely with me, our management team and all our employees to achieve our goal: to become an innovative player in France and internationally, a leader in less invasive spine treatments.”

Next event:
November 10, 2023: Extraordinary General Meeting

SPINEWAY ELIGIBLE FOR PEA-SME (Small and Medium Business Equity Savings Plans)
Find out all about Spineway at www.spineway.com

This press release has been drawn up in both English and French. In case of contradictions, the French version shall prevail.

Spineway designs, produces and sells innovative implants and surgical instruments for the treatment of serious spinal conditions.
Spineway has an international network of more than 50 independent distributors and 90% of its turnover comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specialized in innovation), has received the OSEO Excellence Award since 2011 and the Deloitte Fast 50 Award (2011). Rhône Alpes INPI Patent Innovation Award (2013) – INPI Talent Award (2015).
ISIN: FR001400BVK2 – ALSPW

Contacts:

SPINEWAY

Shareholder services line

Available from Tuesday to Thursday

+33 (0)806 706 060

Suitable PEA/PME

ALSPW

Euonext growth

HEAVEN

Office & Communications

Relations with investors

Solène Kennis